Abstract:To study the correlation between chronic inflammation and PCOS. Part 1: Thirty cases of PCOS with insulin resistance (Homa index≥2.69), thirty cases of PCOS without insulin resistance (Homa index<2.69) and thirty cases of controls were studied in this experiment. We examined serum levels of the anti-flammatory factor: interleukin1 receptor antagonist (IL1ra), and inflammatory markers: interleukin1β (IL1β), tumor necrosis factor alpha (TNFα). Part 2: We checked the expression of IL1RA and TNF gene in the granulosa cell of five PCOS patients and thirteen controls by real-time PCR. Part 3: One hundred and twenty-nine PCOS patients and eighty-eight controls were examined in this study. We analyzed the IL1RA gene polymorphism by PCR. Part 1: Serum levels of IL1ra, IL1β and TNFα were measured by ELISA (Biosource Inc). Part 2: RNA was isolated from granulosa cell and the real-time PCR reactions were carried out. Part 3: Genomic DNA was extracted from peripheral blood and PCR reactions were carried out. All of the data were analyzed by SPSS11.5. Part 1: 1. In the PCOS insulin resistance group, serum IL1ra, IL1β and TNFα concentrations were increased in comparison with the other two groups (P<0.05), moreover, PCOS without insulin resistance patients were also higher than the controls (P<0.05). IL1ra/IL1β was the opposite (P<0.05). 2. Serum level of IL1ra, IL1β and TNFα were higher in PCOS obese women (BMI ≥ 25kg/m2) than in PCOS lean women (BMI < 25kg/m2), but IL1ra/IL1β was the opposite (P<0.05). 3. Serum level of IL1ra, IL1β and TNFα were higher in PCOS women with normal BMI than in controls with normal BMI (P<0.05). Part 2: The expression of IL1RA and TNF gene in granulosa cell of PCOS patients were up-regulation 15.67 times and 4.26 times comparing with the controls (P<0.05). Part 3: 1. The IL1RA allele 5 frequencies among women with PCOS and controls were 5.4% and 0% (P<0.05). 2. We discovered BMI of the PCOS patients with polymorphic allele 5 was 26.66 ± 3.41kg/m2 higher than the PCOS patients without allele 5 (24.42 ± 3.84 kg/m2) (P<0.05). PCOS had correlation with chronic low-grade inflammation and had reference to insulin resistance and obesity. We presumed there was a balance of inflammation and anti-inflammation in PCOS patients. IL1RA polymorphic allele 5 may have correlation with the presence of PCOS, and PCOS people with IL1RA allele 5 may have a propensity for obesity.

Insulin-like peptide 5 is associated with insulin resistance in women with polycystic ovary syndrome

Insulin-like Peptide 5 (INSL5) Positively Correlates with Anti-Müllerian Hormone (AMH) in Women with the Polycystic Ovary Syndrome: a Case-Control Study.

The Association Between Polymorphism Of Insr And Polycystic Ovary Syndrome: A Meta-Analysis

Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome

Elevated circulating GPHB5 levels in women with insulin resistance and polycystic ovary syndrome: A cross-sectional study and multiple intervention studies

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

INSULIN RESISTANCE AND POLYCYSTIC OVARY SYNDROME IN A CHINESE POPULATION.

The occurrence of insulin resistance and metabolic syndrome in polycystic ovary syndrome

Association Between Serum Level of Interleukin-18 and Insulin Resistance in Women with Polycystic Ovary Syndrome

Downregulation of serum long noncoding RNA GAS5 may contribute to insulin resistance in PCOS patients

Association of Insulin-Like Growth Factor-1 with Polycystic Ovarian Syndrome: A Systematic Review and Meta-analysis.

Elevated Circulating Levels of Irisin and the Effect of Metformin Treatment in Women with Polycystic Ovary Syndrome.

Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine

The association between the insulin gene polymorphism and polycystic ovary syndrome

Clinical study of insulin resistance in women with polycystic ovary syndrome

Adipokines and soluble cell adhesion molecules in insulin resistant and non-insulin resistant women with polycystic ovary syndrome

Insulin-like growth factor binding protein-1 and insulin in polycystic ovary syndrome: a systematic review and meta-analysis

[The effects of hyperinsulinmia and insulin-like growth factor-1 on hyperandrogenism in polycystic ovarian syndrome]

Relationship between the Insulin Gene Polymorphism and Polycystic Ovary Syndrome

Increased GPC4 and clusterin associated with insulin resistance in patients with PCOS

Study on the Correlation Between Low-Grade Chronic Inflammation and Pathogenesis of Polycystic Ovary Syndrome